The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease

Jodi Taylor, Lauren J Scott, Chris A Rogers, A Muldrew, D O'Reilly , S Wordsworth , Nicola J Mills, R Hogg, M Violato, SP Harding, T Peto, Daisy Townsend, Usha Chakravarthy, Barnaby C Reeves

Research output: Contribution to journalArticle (Academic Journal)peer-review

4 Citations (Scopus)
323 Downloads (Pure)

Abstract

Introduction

Standard treatment for neovascular age-related macular degeneration (nAMD) is intravitreal injections of anti-VEGF drugs. Following multiple injections, nAMD lesions often become quiescent but there is a high risk of reactivation, and regular review by hospital ophthalmologists is the norm. The present trial examines the feasibility of community optometrists making lesion reactivation decisions.

Methods

The Effectiveness of Community vs Hospital Eye Service (ECHoES) trial is a virtual trial; lesion reactivation decisions were made about vignettes that comprised clinical data, colour fundus photographs, and optical coherence tomograms displayed on a web-based platform. Participants were either hospital ophthalmologists or community optometrists. All participants were provided with webinar training on the disease, its management, and assessment of the retinal imaging outputs. In a balanced design, 96 participants each assessed 42 vignettes; a total of 288 vignettes were assessed seven times by each professional group.

The primary outcome is a participant’s judgement of lesion reactivation compared with a reference standard. Secondary outcomes are the frequency of sight threatening errors; judgements about specific lesion components; participant-rated confidence in their decisions about the primary outcome; cost effectiveness of follow-up by optometrists rather than ophthalmologists.

Discussion

This trial addresses an important question for the NHS, namely whether, with appropriate training, community optometrists can make retreatment decisions for patients with nAMD to the same standard as hospital ophthalmologists. The trial employed a novel approach as participation was entirely through a web-based application; the trial required very few resources compared with those that would have been needed for a conventional randomised controlled clinical trial.
Original languageEnglish
Pages (from-to)68-78
Number of pages11
JournalEye
Volume30
Early online date9 Oct 2015
DOIs
Publication statusPublished - 1 Jan 2016

Structured keywords

  • BTC (Bristol Trials Centre)

Fingerprint

Dive into the research topics of 'The design and implementation of a study to investigate the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease'. Together they form a unique fingerprint.

Cite this